摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-(Acetyloxy)-7-hydroxy-2-phenyl-4H-1-benzopyran-4-one | 132351-59-8

中文名称
——
中文别名
——
英文名称
8-(Acetyloxy)-7-hydroxy-2-phenyl-4H-1-benzopyran-4-one
英文别名
(7-hydroxy-4-oxo-2-phenylchromen-8-yl) acetate
8-(Acetyloxy)-7-hydroxy-2-phenyl-4H-1-benzopyran-4-one化学式
CAS
132351-59-8
化学式
C17H12O5
mdl
——
分子量
296.27
InChiKey
POHKBKXKMFAFGQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    22
  • 可旋转键数:
    3
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    72.8
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Substituted benzopyranones as telomerase inhibitors
    申请人:——
    公开号:US20020160983A1
    公开(公告)日:2002-10-31
    The present invention relates to benzopyranone derivatives, to methods for treating telomerase-modulated diseases, in particular cancers, with said derivatives, to a process for their preparation, to their use as medicaments and to pharmaceutical compositions comprising them.
    本发明涉及苯并吡喃酮衍生物,涉及使用所述衍生物治疗端粒酶调节疾病的方法,特别是癌症,涉及它们的制备过程,它们作为药物的使用,以及包含它们的药物组合物。
  • [EN] Substituted Dihydroxyflavone Derivatives, Compositions, and Methods Related Thereto<br/>[FR] DÉRIVÉS DE DIHYDROXYFLAVONE SUBSTITUÉS, COMPOSITIONS ET PROCÉDÉS ASSOCIÉS
    申请人:UNIV EMORY
    公开号:WO2020033960A1
    公开(公告)日:2020-02-13
    In certain embodiments, the disclosure relates to heterocyclic flavone derivatives, such as those described by formula provided herein, pharmaceutical compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing diseases or conditions related to BDNF and TrkB activity, such as depression, stroke, Rett syndrome, Parkinson's disease, and Alzheimer's disease by administering effective amounts of pharmaceutical compositions comprising compounds disclosed herein to a subject in need thereof.
    在某些实施例中,该公开涉及杂环黄酮衍生物,例如本文提供的公式所描述的那些,制药组合物,以及相关方法。在某些实施例中,该公开涉及治疗或预防与BDNF和TrkB活性相关的疾病或症状的方法,如抑郁症、中风、雷特综合征、帕金森病和阿尔茨海默病,通过向需要的受试者投与本文披露的化合物组成的制药组合物的有效量。
  • SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS
    申请人:Pharmacia Italia S.p.A.
    公开号:EP1373244A2
    公开(公告)日:2004-01-02
  • [EN] SUBSTITUTED BENZOPYRANONES AS TELOMERASE INHIBITORS<br/>[FR] BENZOPYRANONES SUBSTITUES UTILISES EN TANT QU'INHIBITEURS DE TELOMERASE
    申请人:PHARMACIA ITALIA SPA
    公开号:WO2002074036A2
    公开(公告)日:2002-09-26
    The present invention relates to benzopyranone derivative, to methods for treating telomerase-modulated diseases, in particular cancers, with said derivatives, to a process for their preparation, to their use as medicaments and to pharmaceutical compositions comprising them.
查看更多